Detalles de la búsqueda
1.
Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201).
Oncologist
; 27(5): 340-e374, 2022 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303078
2.
Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603.
Oncologist
; 27(8): e642-e649, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579511
3.
Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer.
Support Care Cancer
; 30(6): 5351-5359, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292848
4.
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.
Int J Clin Oncol
; 23(1): 1-34, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28349281
5.
Phase 1 study of OCV-C02, a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancer.
Cancer Sci
; 108(5): 1013-1021, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28266765
6.
Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.
BMC Cancer
; 17(1): 837, 2017 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29221445
7.
Successful Treatment with 5-fluorouracil and Levofolinate Calcium in Advanced Gastric Cancer Patient with Disseminated Intravascular Coagulation.
Gan To Kagaku Ryoho
; 44(10): 867-869, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29066681
8.
Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial).
Gastric Cancer
; 19(2): 350-360, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26385385
9.
Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.
Gastric Cancer
; 18(4): 824-32, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25185971
10.
The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer.
Future Oncol
; 11(10): 1471-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25963425
11.
Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP.
Future Oncol
; 11(4): 617-27, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25686117
12.
A randomized Phase III trial of weekly or 3-weekly doses of nab-paclitaxel versus weekly doses of Cremophor-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE Trial).
Jpn J Clin Oncol
; 45(3): 303-6, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25516635
13.
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer.
Int J Clin Oncol
; 20(2): 207-39, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25782566
14.
Severe infusion reactions to cetuximab occur within 1 h in patients with metastatic colorectal cancer: results of a nationwide, multicenter, prospective registry study of 2126 patients in Japan.
Jpn J Clin Oncol
; 44(6): 541-6, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24771864
15.
Incidence and clinical features of drug-induced lung injury in patients with advanced colorectal cancer receiving cetuximab: results of a prospective multicenter registry.
Jpn J Clin Oncol
; 44(11): 1032-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25210144
16.
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 14(13): 1278-86, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24225157
17.
Correlation of multiple endpoints in the first-line chemotherapy of advanced gastric cancer: Pooled analysis of individual patient data from Japanese Phase III trials.
Cancer Med
; 2023 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140879
18.
Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101).
J Clin Med
; 12(4)2023 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36836140
19.
Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer.
Acta Oncol
; 51(7): 867-72, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22554343
20.
A Japanese post-marketing surveillance of cetuximab (Erbitux®) in patients with metastatic colorectal cancer.
Jpn J Clin Oncol
; 42(4): 287-94, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22327124